CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 180 enrolled
Drug / intervention
Metoclopramide +2 moredrug
Likely dose
Metoclopramide 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02959840
NCT02959840Phase 4Completed

Is Intra-operative Acupuncture Point P6 Stimulation as Effective as Traditional Pharmacotherapy in Reducing Nausea and Vomiting During Cesarean Section With Regional Anesthesia?

Rutgers, The State University of New Jersey·interventional·Posted Nov 9, 2016·Updated Sep 25, 2017

In Brief

A Phase 4 clinical trial evaluating Acupressure Point P6 stimulator, Metoclopramide, and 1 other intervention for Nausea and 2 related conditions. Completed, enrolled 180 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the effectiveness of acupressure point P6 stimulation versus intravenous ondansetron plus metoclopramide versus no antiemetic prophylaxis during elective cesarean section under regional anesthesia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 9, 2016
Enrollment StartJul 1, 2015
Primary CompletionMar 1, 2016
Study CompletionAug 23, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.6 years ago

Interventions

Acupressure Point P6 stimulatordevice

This device stimulates the chi channel at the master of the heart (MH8 position) at the small depression of the volar surface of the distal right forearm just above the crest of the wrist. The device is placed on patients in the operating room prior to administration of the regional anesthesia and will be removed after the cesarean section is complete. The device is removed from the patient in the operating room, before the patient is transported to the recovery room. Patients receive continuous stimulation at a level that is comfortable for the patient prior to administration of the standardized regional anesthesia.

Metoclopramidedrug

10 mg Reglan IV immediately prior to administration of the standardized regional anesthesia.

Ondansetrondrug

8 mg of Zofran IV immediately prior to administration of the standardized regional anesthesia.